[16,16-Dimethylprostaglandin E2. Antisecretory and protective effects on human gastric mucosa].
The effect of graded oral doses of 16,16-dimethyl-prostaglandin E2 (PG E2) on basal acid secretion in healthy volunteers was tested over a time period of 6 h. In addition, studies were conducted to determine whether pretreatment with this methylated PG-analog could prevent the characteristic fall in human gastric potential difference (PD) associated with intragastric instillation of 50 ml of 4 mmol/l Na-taurocholate. Basal acid output was reduced by 80--90% after 0.5 microgram/kg b.w. 16,16-dimethyl-PG E2. Half maximum inhibition was achieved by 0.1 microgram/kg b.w., whereas a 10 fold lower dose of 16,16-dimethyl-PG E2 (0.01 microgram/kg b.w.) effectively protected human gastric mucosa against the injurious effects of Na-taurocholate. In analogy to findings in animals it is, therefore, concluded that 16,16-dimethyl-PG E2 has two distinct properties in human stomach, antisecretory and protective ones, which were independent of each other.
D015064:16,16-Dimethylprostaglandin E2 / Q000494:pharmacology*; D000328:Adult; D005744:Gastric Acid / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects*; D006801:Humans; D008297:Male; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology*; D013656:Taurocholic Acid / Q000494:pharmacology; D013997:Time Factors
D011459:Prostaglandins E, Synthetic; D013656:Taurocholic Acid; D015064:16,16-Dimethylprostaglandin E2
16,16-dimethyl-prostaglandin E2. Säurehemmung und Schleimhautschutz beim Menschen.